Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review

BACKGROUND: Based on current evidence, recent guidelines of the National Institute of Health, USA indicated the use of remdesivir and dexamethasone for the treatment of COVID-19 patients with mild-moderate disease, not requiring high-flow oxygen. No therapeutic agent directed against the immunologic...

詳細記述

保存先:
書誌詳細
出版年:Drugs
主要な著者: Cantini, Fabrizio, Goletti, Delia, Petrone, Linda, Najafi Fard, Saied, Niccoli, Laura, Foti, Rosario
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2020
主題:
Systematic Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7568461/
https://ncbi.nlm.nih.gov/pubmed/33068263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01421-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料